For a collaboration of Dr. Carolyn Bertozzi, Dr. Catherine Blish and Dr. Marie Hollenhorst to identify minimally invasive predictive biomarkers for Covid-19 disease progression to improve scarce resource allocation.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Carolyn BertozziResearch Location
United States of AmericaLead Research Institution
Stanford UniversityResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable